Výsledky vyhledávání

Akademický článek

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021).

Autor: Sportiello L; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., La Mantia G; Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility, and Continuity of Care, University Hospital Palermo, Palermo, Italy.; Department Me.Pre.CC, University of Palermo, Palermo, Italy.; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy., Panzarella V; Department Me.Pre.CC, University of Palermo, Palermo, Italy., Colella G; Oral and Maxillofacial Surgery Unit, Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania 'Luigi Vanvitelli', Naples, Italy., Potenza S; Italian Medicines Agency, Rome, Italy., Oteri G; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy., Sottosanti L; Italian Medicines Agency, Rome, Italy., Bellavia G; Department of Drug, ASP Agrigento, Agrigento, Italy., Gaio M; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Zinzi A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Morreale I; Internal Medicine, Pharmacovigilance and Clinical Pharmacology Unit, Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (PROMISE) G. D'Alessandro, Sicilian Regional Pharmacovigilance Centre, University of Palermo, Palermo, Italy., Parrinello G; Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (PROMISE) G. D'Alessandro, University of Palermo, Palermo, Italy., Geninatti E; Piedmont Regional Centre for Pharmacovigilance, Turin, Italy., Marrazzo E; Piedmont Regional Centre for Pharmacovigilance, Turin, Italy., Fusco V; Oncology Unit, Azienda Ospedaliera Di Alessandria SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Capuano A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Campisi G; Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility, and Continuity of Care, University Hospital Palermo, Palermo, Italy.; Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Publikováno v: Oral diseases [Oral Dis] 2024 Oct 06. Date of Electronic Publication: 2024 Oct 06.

Zobrazit plný text záznamu

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

Autor: Ahmadizar F., Luxi N., Raethke M., Schmikli S., Riefolo F., Saraswati P. W., Bucsa C., Osman A., Liddiard M., Maques F. B., Petrelli G., Sonderlichova S., Thurin N. H., Villalobos F., Trifiro G., Sturkenboom M., Moretti U., Bellitto C., Ciccimarra F., Gonella L. A., Arzenton E., Chiamulera C., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Cutroneo P. M., Minore C., Costantino C., Vitale F., D'Alessandro G., Morreale I., Marsala L., Farinella D., Bavetta S., Fantini M. P., Reno C., Raschi E., Poluzzi E., Sapigni E., Potenza A. M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M. S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Gavioli B., Palazzi S., Tuccori M., Vannacci A., Bonaiuti R., Ravaldi C., Lombardi N., Crescioli G., Gori F., Tessari R., Zandona E., Zanoni G., Senna G., Crivellaro M. A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Capuano A., Rafaniello C., Ferrajolo C., Pagliaro C., Mercaldo M., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., de Sarro C., Verduci C., Papadopoli R., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V., Mastropasqua D.

Background and Objectives: The European Medicine Agency extended the use of Comirnaty, Spikevax, and Nuvaxovid in paediatrics; thus, these vaccines require additional real-world safety evidence. Herein, we aimed to monitor the safety of COVID-19 vacc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::c8916ae0b4845b6e45ea4bd7d0d193b1
https://hdl.handle.net/11585/928075

Zobrazit plný text záznamu

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

Autor: Luxi N., Giovanazzi A., Capuano A., Crisafulli S., Cutroneo P. M., Fantini M. P., Ferrajolo C., Moretti U., Poluzzi E., Raschi E., Ravaldi C., Reno C., Tuccori M., Vannacci A., Zanoni G., Trifiro G., Petrelli G., Girotti S., Arzenton E., Magro L., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Spina E., Minore C., Costantino C., Conforto A., Vitale F., Morreale I., Marsala L., Farinella D., Bavetta S., Sapigni E., Potenza A. M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M. S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Pappalardo F., Bonaiuti R., Lombardi N., Crescioli G., Tessari R., Zandona E., Marchiori F., Chiamulera C., Senna G., Crivellaro M. A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Rafaniello C., Pagliaro C., Mercaldo M., Fucile A., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Leopardi E., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V.

Publikováno v: Drug Safety

To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vaxzevria (prev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbb1fe9555478fb36e1a7ddd4735ab1
http://hdl.handle.net/11585/851640

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

A questionable diagnosis in a woman with drowsiness.

Autor: Minissale MG; Medicina Interna ed Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica 'G. D'Alessandro', PROMISE, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy. mgminissale@gmail.com., Giannitrapani L; Medicina Interna ed Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica 'G. D'Alessandro', PROMISE, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy., Capitano A; Medicina Interna ed Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica 'G. D'Alessandro', PROMISE, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy., Morreale I; Unità di Farmacologia Clinica, Centro di Riferimento Siciliano per la Farmacovigilanza, AOUP P. Giaccone, Università di Palermo, Palermo, Italy., Licata A; Medicina Interna ed Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica 'G. D'Alessandro', PROMISE, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy.

Publikováno v: Internal and emergency medicine [Intern Emerg Med] 2021 Jun; Vol. 16 (4), pp. 1017-1021. Date of Electronic Publication: 2019 Dec 17.

Zobrazit plný text záznamu

Report

Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature.

Autor: Santoro M; Department of Surgical, Oncological and Stomatological Disciplines, University of Palermo, Palermo, Italy., Rotolo C; Hematology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy., Accurso V; Hematology Unit, University Hospital 'Paolo Giaccone,', Palermo, Italy., Morreale I; Clinical Pharmacology Unit, Department of Hospital General Services, University Hospital 'Paolo Giaccone,', Palermo, Italy., Mancuso S; Hematology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy., Siragusa S; Hematology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.

Publikováno v: Chemotherapy [Chemotherapy] 2021; Vol. 66 (3), pp. 87-91. Date of Electronic Publication: 2021 Mar 30.

Zobrazit plný text záznamu

Farmacovigilanza attiva sul ruolo dei farmaci antiangiogenetici nell’osteonecrosi dei mascellari

Autor: Morreale, I, MELI, Maria, DI FEDE, Olga, CAMPISI, Giuseppina, D'ALESSANDRO, Natale

Farmacovigilanza attiva sul ruolo dei farmaci antiangiogenetici nell’osteonecrosi dei mascellari Ilaria Morreale1, Maria Meli1, Olga Di Fede2, Giuseppina Campisi2, Natale D’Alessandro1 1Centro di consulenza sulle reazioni avverse da farmaci in on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::61528ce2b9925893d8a9578c6dc94db1
http://hdl.handle.net/10447/90226

Zobrazit plný text záznamu

The use of low molecular weight heparin in a Sicilian teaching hospital

Autor: MELI, Maria, MALTA, Renato, D'ALESSANDRO, Natale, Pasquale, A, Morreale, I, La Seta, C, Di Rosa, S

LMWH are replacing unfractionated heparin (UFH) for therapeutic anticoagulation owing to their more predictable pharmacokinetics and ease of use. Especially in Sicily, their prescription volume is steadily increasing in general practice, but little i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::3815d8ef082c54f71d8757f3f1fd063c
http://hdl.handle.net/10447/79730

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání